Question:
Phase 3
Author: LEIGHTON DWIGHT OBILLOSAnswer:
- 1000+ individuals with the target disease - Test: Efficacy in a normal clinical condition - Know how to achieve better bioavailability
0 / 5 Â (0 ratings)
1 answer(s) in total
Author
LEIGHTON DWIGHT OBILLOS